{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:04:25Z","timestamp":1789761865615,"version":"4.0.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.urolonc.2026.07.008","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:43:48Z","timestamp":1786131828000},"page":"796-804","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predicting long-term metastatic risk after radical prostatectomy: Adding Genomic Prostate Score, grade group, and cribriform size to unfavorable histology burden translates into minimal incremental discrimination"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-6596-9100","authenticated-orcid":false,"given":"Salim K.","family":"Younis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamilla","family":"Abdurakhmanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Dortche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Watfa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui M.","family":"Bernardino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman","family":"Al-Bayati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betty","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gagandeep","family":"Fervaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Olivares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Autorino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane K.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihad","family":"Kaouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyad R.","family":"Schwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse K.","family":"McKenney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Weight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.urolonc.2026.07.008_bib0001","first-page":"485","article-title":"Prostate cancer statistics, 2025","volume":"75","author":"Kratzer","year":"2025","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.urolonc.2026.07.008_bib0002","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.56825","article-title":"Trends in prostate cancer incidence and mortality rates","volume":"8","author":"Van Blarigan","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.urolonc.2026.07.008_bib0003","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/JU.0000000000002757","article-title":"Clinically localized prostate cancer: AUA\/ASTRO guideline, Part I: introduction, risk assessment, staging, and risk-based management","volume":"208","author":"Eastham","year":"2022","journal-title":"J Urol"},{"issue":"24","key":"10.1016\/j.urolonc.2026.07.008_bib0004","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1001\/jama.2024.6695","article-title":"Long-term outcomes in patients using protocol-directed active surveillance for prostate cancer","volume":"331","author":"Newcomb","year":"2024","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.urolonc.2026.07.008_bib0005","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41379-018-0157-9","article-title":"Large cribriform growth pattern identifies ISUP grade 2 prostate cancer at high risk for recurrence and metastasis","volume":"32","author":"Hollemans","year":"2019","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.urolonc.2026.07.008_bib0006","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1309\/AJCPZ7WBU9YXSJPE","article-title":"Digital quantification of five high-grade prostate cancer patterns, including the cribriform pattern, and their association with adverse outcome","volume":"136","author":"Iczkowski","year":"2011","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"10.1016\/j.urolonc.2026.07.008_bib0007","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/modpathol.2016.49","article-title":"Disease-specific survival of patients with invasive cribriform and intraductal prostate cancer at diagnostic biopsy","volume":"29","author":"Kweldam","year":"2016","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.urolonc.2026.07.008_bib0008","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/modpathol.2014.116","article-title":"Cribriform growth is highly predictive for postoperative metastasis and disease-specific death in Gleason score 7 prostate cancer","volume":"28","author":"Kweldam","year":"2015","journal-title":"Mod Pathol"},{"issue":"11","key":"10.1016\/j.urolonc.2026.07.008_bib0009","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1097\/PAS.0000000000000736","article-title":"Histologic grading of prostatic adenocarcinoma can be further optimized: analysis of the relative prognostic strength of individual architectural patterns in 1275 patients from the canary retrospective cohort","volume":"40","author":"McKenney","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.urolonc.2026.07.008_bib0010","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/his.14214","article-title":"Prostate cancer growth patterns beyond the Gleason score: entering a new era of comprehensive tumour grading","volume":"77","author":"van Leenders","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.urolonc.2026.07.008_bib0011","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ejca.2020.09.016","article-title":"Cribriform architecture prostatic adenocarcinoma in needle biopsies is a strong independent predictor for lymph node metastases in radical prostatectomy","volume":"148","author":"Downes","year":"2021","journal-title":"Eur J Cancer"},{"issue":"9","key":"10.1016\/j.urolonc.2026.07.008_bib0012","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.ejca.2014.03.009","article-title":"Prognostic impact of intraductal carcinoma and large cribriform carcinoma architecture after prostatectomy in a contemporary cohort","volume":"50","author":"Trudel","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.urolonc.2026.07.008_bib0013","article-title":"Gleason grade group 3 represents a spectrum of disease: results from a large institutional cohort","author":"Shee","year":"2025","journal-title":"Eur Urol Focus"},{"issue":"3","key":"10.1016\/j.urolonc.2026.07.008_bib0014","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/his.14590","article-title":"Cribriform architecture outperforms Gleason pattern 4 percentage and tertiary Gleason pattern 5 in predicting the outcome of Grade Group 2 prostate cancer patients","volume":"80","author":"Seyrek","year":"2022","journal-title":"Histopathology"},{"issue":"5","key":"10.1016\/j.urolonc.2026.07.008_bib0015","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/his.14064","article-title":"Clinical outcome comparison of Grade Group 1 and Grade Group 2 prostate cancer with and without cribriform architecture at the time of radical prostatectomy","volume":"76","author":"Hollemans","year":"2020","journal-title":"Histopathology"},{"issue":"6","key":"10.1016\/j.urolonc.2026.07.008_bib0016","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.eururo.2020.08.004","article-title":"The 2019 international society of urological pathology consensus conference on prostate cancer grading","volume":"79","author":"van Leenders","year":"2021","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2026.07.008_bib0017","doi-asserted-by":"crossref","first-page":"461","DOI":"10.5858\/arpa.2020-0015-RA","article-title":"The 2019 Genitourinary Pathology Society (GUPS) White Paper on contemporary grading of prostate cancer","volume":"145","author":"Epstein","year":"2021","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"10.1016\/j.urolonc.2026.07.008_bib0018","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/his.15231","article-title":"Proposal for an optimised definition of adverse pathology (unfavourable histology) that predicts metastatic risk in prostatic adenocarcinoma independent of grade group and pathological stage","volume":"85","author":"Nguyen","year":"2024","journal-title":"Histopathology"},{"issue":"8","key":"10.1016\/j.urolonc.2026.07.008_bib0019","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/s41379-022-01009-7","article-title":"Analysis of separate training and validation radical prostatectomy cohorts identifies 0.25 mm diameter as an optimal definition for \"large\" cribriform prostatic adenocarcinoma","volume":"35","author":"Chan","year":"2022","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.urolonc.2026.07.008_bib0020","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/his.15102","article-title":"Large cribriform glands (>0.25 mm diameter) as a predictor of adverse pathology in men with Grade Group 2 prostate cancer","volume":"84","author":"Greenland","year":"2024","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.urolonc.2026.07.008_bib0021","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/his.70036","article-title":"Correlation of unfavourable and favourable histology at radical prostatectomy with Decipher scores and freedom from biochemical recurrence","volume":"88","author":"Greenland","year":"2026","journal-title":"Histopathology"},{"key":"10.1016\/j.urolonc.2026.07.008_bib0022","first-page":"5","article-title":"GPS assay association with long-term cancer outcomes: twenty-year risk of distant metastasis and prostate cancer-specific mortality","author":"Brooks","year":"2021","journal-title":"JCO Precis Oncol"},{"issue":"4","key":"10.1016\/j.urolonc.2026.07.008_bib0023","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/pcan.2016.38","article-title":"Decipher correlation patterns post prostatectomy: initial experience from 2 342 prospective patients","volume":"19","author":"Den","year":"2016","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"13","key":"10.1016\/j.urolonc.2026.07.008_bib0024","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1200\/JCO.19.02768","article-title":"Molecular biomarkers in localized prostate cancer: ASCO guideline","volume":"38","author":"Eggener","year":"2020","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.urolonc.2026.07.008_bib0025","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/j.juro.2013.06.017","article-title":"Validation of a genomic classifier that predicts metastasis following radical prostatectomy in an at risk patient population","volume":"190","author":"Karnes","year":"2013","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.urolonc.2026.07.008_bib0026","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.euo.2025.08.002","article-title":"Clinical comparison of decipher 1.0 and 1.1 for localized prostate cancer: results in prostatectomy and active surveillance patients","volume":"8","author":"Raizenne","year":"2025","journal-title":"Eur Urol Oncol"},{"issue":"1","key":"10.1016\/j.urolonc.2026.07.008_bib0027","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.eururo.2015.05.042","article-title":"Tissue-based genomics augments post-prostatectomy risk stratification in a natural history cohort of intermediate- and high-risk men","volume":"69","author":"Ross","year":"2016","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.urolonc.2026.07.008_bib0028","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.eururo.2014.05.004","article-title":"A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling","volume":"66","author":"Klein","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2026.07.008_bib0029","series-title":"Urinary and male genital tumours.","first-page":"200","article-title":"Intraductal carcinoma of the prostate","author":"Zhou","year":"2022"},{"issue":"5","key":"10.1016\/j.urolonc.2026.07.008_bib0030","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/his.15525","article-title":"Classification of prostatic adenocarcinoma as favourable\/unfavourable histology has high interobserver agreement in prostate needle core biopsies","volume":"87","author":"Ding","year":"2025","journal-title":"Histopathology"},{"issue":"10","key":"10.1016\/j.urolonc.2026.07.008_bib0031","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.3348\/kjr.2021.0223","article-title":"Review of statistical methods for evaluating the performance of survival or other time-to-event prediction models (from conventional to deep learning approaches)","volume":"22","author":"Park","year":"2021","journal-title":"Korean J Radiol"},{"issue":"1","key":"10.1016\/j.urolonc.2026.07.008_bib0032","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12916-019-1466-7","article-title":"Calibration: the Achilles heel of predictive analytics","volume":"17","author":"Van Calster","year":"2019","journal-title":"BMC Med"},{"issue":"2","key":"10.1016\/j.urolonc.2026.07.008_bib0033","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/s41391-024-00802-6","article-title":"Does prostate cancer without cribriform pattern have metastatic potential?","volume":"28","author":"Kroon","year":"2025","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"12","key":"10.1016\/j.urolonc.2026.07.008_bib0034","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1001\/jamaoncol.2025.4125","article-title":"Active monitoring, surgery, and radiotherapy for cribriform-positive and cribriform-negative prostate cancer: a secondary analysis of the PROTECT randomized clinical trial","volume":"11","author":"Sushentsev","year":"2025","journal-title":"JAMA Oncol"},{"issue":"4","key":"10.1016\/j.urolonc.2026.07.008_bib0035","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.eururo.2014.10.036","article-title":"A genomic classifier improves prediction of metastatic disease within 5 years after surgery in node-negative high-risk prostate cancer patients managed by radical prostatectomy without adjuvant therapy","volume":"67","author":"Klein","year":"2015","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2026.07.008_bib0036","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/pcan.2013.49","article-title":"A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomy","volume":"17","author":"Ross","year":"2014","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"16","key":"10.1016\/j.urolonc.2026.07.008_bib0037","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/pros.24072","article-title":"Prostate biopsy histopathologic features correlate with a commercial gene expression assay's reclassification of patient NCCN risk category","volume":"80","author":"Greenland","year":"2020","journal-title":"Prostate"},{"issue":"1","key":"10.1016\/j.urolonc.2026.07.008_bib0038","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4111\/icu.20210262","article-title":"Molecular risk classifier score and biochemical recurrence risk are associated with cribriform pattern type in Gleason 3+4=7 prostate cancer","volume":"63","author":"Greenland","year":"2022","journal-title":"Investig Clin Urol"},{"issue":"8","key":"10.1016\/j.urolonc.2026.07.008_bib0039","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1053\/hupa.2001.26456","article-title":"Prognostic significance of the diameter of perineural invasion in radical prostatectomy specimens","volume":"32","author":"Maru","year":"2001","journal-title":"Hum Pathol"},{"issue":"14","key":"10.1016\/j.urolonc.2026.07.008_bib0040","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1200\/JCO.19.02267","article-title":"17-Gene Genomic Prostate Score test results in the canary prostate active surveillance study (PASS) cohort","volume":"38","author":"Lin","year":"2020","journal-title":"J Clin Oncol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143926006083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143926006083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T19:12:18Z","timestamp":1789758738000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143926006083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1078143926006083"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2026.07.008","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting long-term metastatic risk after radical prostatectomy: Adding Genomic Prostate Score, grade group, and cribriform size to unfavorable histology burden translates into minimal incremental discrimination","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2026.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}